Sullivan Christopher Ryan bought AVTX
August 17, 2026 · Form 4 insider transaction
Sullivan Christopher Ryan bought 2,876 shares of Avalo Therapeutics, Inc. at $9.88 per share, a transaction worth $28.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,876
Price
$9.88
Total value
$28.4K
InsiderSullivan Christopher Ryan
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 17, 2026
Filing dateAugust 19, 2026
Shares owned after81,594
OwnershipDirect
10b5-1 planNo
AmendedNo